$1.63
1.24%
Nasdaq, Sep 17, 01:22 pm EDT. Market open.
ISIN
US68375N1037
Symbol
OPK

OPKO Health, Inc. Target price 2026 - Analyst rating & recommendation

OPKO Health, Inc. Classifications & Recommendation

Buy
70%
Hold
30%

OPKO Health, Inc. Price Target

Target Price $3.06
Price $1.61
Potential
Number of Estimates 4
4 Analysts have issued a price target OPKO Health, Inc. 2027 . The average OPKO Health, Inc. target price is $3.06. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 10 analysts: 7 Analysts recommend OPKO Health, Inc. to buy, 3 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the OPKO Health, Inc. stock has an average upside potential 2027 of . Most analysts recommend the OPKO Health, Inc. stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Million $ 606.88 575.59
14.90% 5.16%
EBITDA Margin -23.25% -9.23%
13.15% 60.30%
Net Margin -37.19% -28.53%
398.30% 23.28%

7 Analysts have issued a sales forecast OPKO Health, Inc. 2026 . The average OPKO Health, Inc. sales estimate is

$576m
unlock
. This is
2.09% lower
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$601m 2.30%
unlock
, the lowest is
$555m 5.58%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $607m 14.90%
2026
$576m 5.16%
unlock
2027
$595m 3.34%
unlock
2028
$612m 2.86%
unlock
2029
$656m 7.25%
unlock
2030
$705m 7.49%
unlock
2031
$724m 2.69%
unlock
2032
$760m 4.88%
unlock
2033
$797m 4.93%
unlock

3 Analysts have issued an OPKO Health, Inc. EBITDA forecast 2026. The average OPKO Health, Inc. EBITDA estimate is

$-53.1m
unlock
. This is
41.86% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-55.2m 39.55%
unlock
, the lowest is
$-51.5m 43.58%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $-141m 26.09%
2026
$-53.1m 62.35%
unlock
2027
$-50.9m 4.18%
unlock
2028
$-31.7m 37.70%
unlock
2029
$98.5m 410.51%
unlock
2030
$117m 18.87%
unlock
2031
$174m 48.49%
unlock
2032
$198m 13.66%
unlock
2033
$207m 4.90%
unlock

EBITDA Margin

2025 -23.25% 13.15%
2026
-9.23% 60.30%
unlock
2027
-8.56% 7.26%
unlock
2028
-5.18% 39.49%
unlock
2029
15.01% 389.77%
unlock
2030
16.60% 10.59%
unlock
2031
24.00% 44.58%
unlock
2032
26.00% 8.33%
unlock
2033
26.00% 0.00%
unlock

7 OPKO Health, Inc. Analysts have issued a net profit forecast 2026. The average OPKO Health, Inc. net profit estimate is

$-164m
unlock
. This is
125.33% lower
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-141m 93.41%
unlock
, the lowest is
$-175m 140.71%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $-226m 324.05%
2026
$-164m 27.22%
unlock
2027
$-205m 24.62%
unlock
2028
$-185m 9.82%
unlock

Net Margin

2025 -37.19% 398.30%
2026
-28.53% 23.28%
unlock
2027
-34.41% 20.61%
unlock
2028
-30.17% 12.32%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ -0.30 -0.22
275.00% 26.67%
P/E negative
EV/Sales 2.18

7 Analysts have issued a OPKO Health, Inc. forecast for earnings per share. The average OPKO Health, Inc. EPS is

$-0.22
unlock
. This is
120.00% lower
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$-0.19 90.00%
unlock
, the lowest is
$-0.24 140.00%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $-0.30 275.00%
2026
$-0.22 26.67%
unlock
2027
$-0.27 22.73%
unlock
2028
$-0.25 7.41%
unlock

P/E ratio

Current -16.10 164.50%
2026
-7.31 54.60%
unlock
2027
-5.87 19.70%
unlock
2028
-6.51 10.90%
unlock

Based on analysts' sales estimates for 2026, the OPKO Health, Inc. stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 2.13 18.99%
2026
2.18 2.28%
unlock
2027
2.11 3.24%
unlock
2028
2.05 2.78%
unlock
2029
1.91 6.76%
unlock
2030
1.78 6.97%
unlock
2031
1.73 2.63%
unlock
2032
1.65 4.65%
unlock
2033
1.57 4.70%
unlock

P/S ratio

Current 2.04 22.13%
2026
2.09 2.14%
unlock
2027
2.02 3.24%
unlock
2028
1.96 2.78%
unlock
2029
1.83 6.76%
unlock
2030
1.70 6.97%
unlock
2031
1.66 2.62%
unlock
2032
1.58 4.65%
unlock
2033
1.51 4.70%
unlock

Current OPKO Health, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Barrington Research
Locked
Locked
Locked Apr 29 2026
Barrington Research
Locked
Locked
Locked Mar 02 2026
JP Morgan
Locked
Locked
Locked Nov 20 2025
Jefferies
Locked
Locked
Locked Oct 31 2025
Barrington Research
Locked
Locked
Locked Oct 30 2025
Barrington Research
Locked
Locked
Locked May 01 2025
JP Morgan
Locked
Locked
Locked Apr 25 2025
Analyst Rating Date
Locked
Barrington Research:
Locked
Locked
Apr 29 2026
Locked
Barrington Research:
Locked
Locked
Mar 02 2026
Locked
JP Morgan:
Locked
Locked
Nov 20 2025
Locked
Jefferies:
Locked
Locked
Oct 31 2025
Locked
Barrington Research:
Locked
Locked
Oct 30 2025
Locked
Barrington Research:
Locked
Locked
May 01 2025
Locked
JP Morgan:
Locked
Locked
Apr 25 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today